Fever - 131 Studies Found
Completed |
: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers : Marburg Hemorrhagic Fever : 2012-03-27 :
|
Completed |
: Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus : Marburg Hemorrhagic Fever : 2011-04-22 :
|
Completed |
: Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults : Hemorrhagic Fever, Ebola : 2015-09-29 : Biological: HPIV3-EbovZ GP Vaccine Administered intranasally by a VaxINator device |
Completed |
: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea : Hemorrhagic Fever, Ebola : 2015-01-12 : Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients. |
Completed |
: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever :
: 2012-05-14 :
|
Completed |
: Experimental Ebola Vaccine Trial :
: 2003-11-04 : Drug: VRC-EBODNA012-00-VP |
Not yet recruiting |
: African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola : Ebola : 2016-12-22 :
|
Recruiting |
: Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen : Ebola Virus Survivor : 2016-02-24 : Drug: Favipiravir Cohort 1: Day 1 (inclusion) 4800 mg (240 |
Recruiting |
: GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen : Persistent Ebola Virus : 2016-06-28 :
|
Active, not recruiting |
: Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) : Prevention of Ebola Infection : 2015-07-17 :
|